ArticleCancer gene therapy2011

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.

T J Harvey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.